John Horan, MD

Trials

Studies that name John Horan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:38 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT03924401 · Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

  Emory University · active not recruiting · Graft Versus Host Disease · principal investigator
• N/A
  NCT01319851 · Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

  Emory University · terminated · Thalassemia, Sickle Cell Disease, Glanzmann Thrombasthenia · principal investigator
• N/A
  NCT00967525 · Intraosseous Infusion of Unrelated Cord Blood Grafts

  Emory University · terminated · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia · principal investigator
• Ph1
  NCT00968162 · Sickle Cell Disease Conditioning for Bone Marrow Transplant

  Emory University · completed · Bone Marrow Transplantation, Sickle Cell Disease · principal investigator
• Ph1
  NCT00967096 · Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)

  Emory University · completed · Malignancy, Bone Marrow Transplantation · principal investigator
• N/A
  NCT00263978 · Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver

  Emory University · no longer available · Liver Diseases · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.